DI GIOVANNI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.846
EU - Europa 2.492
AS - Asia 2.185
SA - Sud America 302
AF - Africa 63
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.897
Nazione #
US - Stati Uniti d'America 4.806
SG - Singapore 767
CN - Cina 574
RU - Federazione Russa 503
UA - Ucraina 461
IT - Italia 387
HK - Hong Kong 269
DE - Germania 267
BR - Brasile 245
VN - Vietnam 204
FI - Finlandia 200
IE - Irlanda 175
JP - Giappone 142
PL - Polonia 131
GB - Regno Unito 124
FR - Francia 98
SE - Svezia 64
KR - Corea 45
IN - India 37
CI - Costa d'Avorio 32
AR - Argentina 22
MX - Messico 20
BD - Bangladesh 19
NL - Olanda 16
TR - Turchia 16
IQ - Iraq 13
ID - Indonesia 12
MT - Malta 12
PH - Filippine 12
PK - Pakistan 12
BE - Belgio 11
CA - Canada 11
RO - Romania 11
CO - Colombia 8
EC - Ecuador 8
PY - Paraguay 8
SA - Arabia Saudita 8
KE - Kenya 7
VE - Venezuela 7
CH - Svizzera 6
JO - Giordania 6
AT - Austria 5
AZ - Azerbaigian 5
ES - Italia 5
GE - Georgia 5
KZ - Kazakistan 5
MA - Marocco 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
AU - Australia 4
IR - Iran 4
KG - Kirghizistan 4
MY - Malesia 4
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
LB - Libano 3
PA - Panama 3
RS - Serbia 3
TN - Tunisia 3
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
LY - Libia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.897
Città #
Ashburn 555
Singapore 529
Fairfield 461
Woodbridge 360
Chandler 306
Houston 305
Hong Kong 263
Jacksonville 259
Ann Arbor 249
San Jose 248
Wilmington 209
Seattle 185
Dublin 175
Cambridge 160
Tokyo 142
Zgierz 129
Frankfurt am Main 118
Santa Clara 110
Beijing 105
Medford 102
Moscow 89
Des Moines 75
Palermo 73
Nanjing 71
Princeton 66
Ho Chi Minh City 63
Lauterbourg 60
Tulsa 59
Hefei 52
Hanoi 50
New York 50
Boardman 45
Altamura 41
Dearborn 39
Buffalo 38
Los Angeles 38
San Diego 38
Lawrence 34
Abidjan 32
Council Bluffs 32
Dallas 27
Milan 27
Chicago 20
Shenyang 20
Changsha 19
Seongnam 19
São Paulo 18
Hebei 17
Haiphong 16
Jiaxing 15
Nanchang 14
Ludwigshafen am Rhein 13
Guangzhou 12
Rio de Janeiro 12
San Paolo di Civitate 12
Tianjin 12
Amsterdam 11
Brussels 11
Da Nang 11
Kumar 11
San Mateo 11
Atlanta 10
Helsinki 10
Jinan 10
Kunming 10
London 10
Auburn Hills 9
Columbus 9
Saint Petersburg 9
Shanghai 9
Cardiff 8
City of London 8
Hangzhou 8
Attard 7
Belo Horizonte 7
Norwalk 7
Phoenix 7
Salt Lake City 7
Biên Hòa 6
Brooklyn 6
Changchun 6
Nairobi 6
Zhengzhou 6
Amman 5
Boston 5
Brasília 5
Elk Grove Village 5
Hải Dương 5
Istanbul 5
Jeddah 5
Southend 5
Verona 5
Asunción 4
Baku 4
Bishkek 4
Bogotá 4
Buenos Aires 4
Bắc Giang 4
Karachi 4
Kiev 4
Totale 6.595
Nome #
Enhanced tonic GABAA inhibition in typical absence epilepsy 262
mGluR control of interneuron output regulates feedforward tonic GABAA inhibition in the visual thalamus 236
Central Serotonin2C Receptor: From Physiology to Pathology. 233
Effects of scopolamine on dopamine neurons in the substantia nigra: Role of the pedunculopontine tegmental nucleus. 230
Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: electrophysiological and neurochemical evidence in rats 230
7-Nitroindazole protects striatal neurons against MPP+ -induced degeneration. 228
Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis 219
Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study. 215
A Diet for Dopaminergic Neurons? 212
Birth, life and death of dopaminergic neurons in the Substantia Nigra 211
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 208
Editorial [ Neurodegenerative Disorders: From Molecules to Man (Part 2) Guest Editors: Giuseppe Di Giovanni, Vincenzo Di Matteo and Ennio Esposito ] 204
Serotonin Involvement in the Basal Ganglia Pathophysiology: Could the 5-HT2C Receptor be a New Target for Therapeutic Strategies?. 186
ANTIOXIDANTS DIETERY INTAKE AND PARKINSON'S DISEASE 185
The Neurobiological Bases for the Pharmacotherapy of Nicotine Addiction. 183
Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. 183
CCK-8S SYSTEMIC ADMINISTRATION BLOCKS THE 7-NITROINDAZOLE-INDUCED EFFECTS ON THE EEG OF STRIATUM AND GLOBUS PALLIDUS: A FFT ANALYSIS IN THE RAT 183
Will it ever become possible to prevent dopaminergic neuronal degeneration? 182
Death in the substantia nigra: a motor tragedy. 170
Nitric Oxide Modulation Of The Basal Ganglia Circuitry: Therapeutic Implication For Parkinson's Disease And Other Motor Disorders 170
THE SUBSTANTIA NIGRA DOPAMINERGIC NEURONS 169
A. Chattopadhyah, Editor, Serotonin Receptors in Neurobiology, CRC Press, Taylor & Francis Group (2007) Price: £79.99, ISBN: 9780849339776. 169
Dopamine interaction with other neurotransmitter systems: Relevance in the pathophysiology and treatment of CNS disorders (editorial) 167
Neuroprotection in Parkinson's disease: a realistic goal? 167
Serotonin-dopamine interaction: electrophysiological evidence 164
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies 161
Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: Implications for seizure susceptibility. 160
Non-steroidal anti-inflammatory drugs in Parkinson’s disease 157
Role of serotonin in central dopamine dysfunction 157
A rapid and quantitative technique to study striatal dopaminergic neurodegeneration by in vivo reverse microdialysis in rats 148
Neurodegenerative disorders: from molecules to man (part 1) 147
Selective Activation of Serotonin2C Receptors Stimulates GABA-ergic Function in the Rat Substantia Nigra Pars Reticulata: A Combined in Vivo Electrophysiological and Neurochemical Study. 145
CRUCIAL ROLE OF THE 5-HT2C RECEPTOR IN REGULATING THE ACTIVITY OF THE SUBSTANTIA NIGRA PARS RETICULATA NEURONS: AN ELECTROPHYSIOLOGICAL STUDY IN RATS 139
ACETYLSALYCILIC ACID (ASA) PROTECTS AGAINST NEURONAL DAMAGE INDUCED BY 1-METHYL-4-PHENYLPYRIDINIUM IODIDE (MPP+) IN RAT STRIATUM: AN IN VIVO MICRODIALYSIS STUDY 139
INFLAMMATION IN PARKINSON'S DISEASE 139
Cholinergic and monoaminergic modulation of tonic GABAA inhibition in the rat dorsal lateral geniculate nucleus 138
Involvement of Nitric Oxide in Nigrostriatal Dopaminergic System Degeneration : A Neurochemical Study. 138
Electrophysiological and neurochemical characterization of 7-nitroindazole and molsidomine acute and sub-chronic administration effects in the dopaminergic nigrostriatal system in rats 133
Involvement of nitric oxide in the nigrostriatal dopaminergic system degeneration: a study on the 6-OHDA model of Parkinson's disease. 132
Unilateral Nigral Lesion Induces Dramatic Bilateral Modification In Rat Brain Monoamine Levels: A Neurochemical Study. 131
Serotonin and Dopamine Interaction: An Overview 131
Serotonin 5-HT2C Receptor and Dopamine Function in Depression 130
Impact of Serotonin 2C Receptor Null Mutation on Physiology and Behavior Associated with Nigrostriatal Dopamine Pathway Function 129
T-patterns in the study of movement and behavioral disorders 129
Nitric oxide influences the activity of neurones in the subthalamic nucleus of the rat. 126
Serotonin Modulation of the Basal Ganglia Circuitry: Therapeutic Implication for Parkinson’s Disease and Other Motor Disorders. 124
Serotonin-Dopamine Interaction: Experimental and Therapeutic Evidence 122
Role of nitric oxide on the conrol of the dopaminergic Nigrostriatal system: a combined electrophysiological And dialysis analysis in rats 121
Modifications induced on rat exploratory behavior by acoustic stimulation: a multivariate analysis 114
Extrasynaptic GABAA receptor gain-of-function in absence epilepsy: GHB and thip pharmacological models 113
The Pivotal Role of Nitric Oxide in 6-OHDA-induced Dopaminergic Neurotoxicity: Neurochemical Evidences in Rats 112
Role of nitric oxide in the controlo of maximal dentate gyrus activation by Lamotrigine in the rat 110
New Serotonin and Dopamine ligands for the treatment of neuropsychiatric disorders. 110
ROLE OF CENTRAL 5-HT2C RECEPTOR IN THE CONTROLL OF BASAL GANGLIA FUNCTIONS 108
MUSCARINIC MODULATION OF THE ACTIVITY OF THE SUBSTANTIA NIGRA PARS COMPACTA NEURONS IN RATS: ROLE OF THE TEGMENTAL PEDUNCULOPONTINE NUCLEUS 107
Microiontophoretic Evidence that Nitric Oxide Alters Spontaneous Activity of the Substantia Nigra Pars Reticulata Neurons in the Rat 107
Selective stimulation of serotonin2c receptors blocks the enhancement of striatal accumbal dopamine release by nicotine administration 102
Preferential modulation of the gabaergic vs. dopaminergic function in the substantia nigra by 5-TH2C receptor signaling: electrophysiological and neurochemical evidence 102
SPECIAL ISSUE "NEURODEGENERATIVE DISORDERS: FROM MOLECULES TO MAN" 102
The Life Cycle of the Dopaminergic Neurons in the Substantia Nigra 101
ROLE OF CENTRAL 5-HT2C RECEPTOR IN THE CONTROLL OF BASAL GANGLIA FUNCTIONS. 99
Electrophysiological and Neurochemical In Vivo Studies on Serotonin 5-HT 2C Control of Central Dopaminergic Function 98
THE BASAL GANGLIA PATHOPHYSIOLOGY: RECENT ADVANCES 97
New Serotonin and Dopamine ligands for the treatment of neuropsychiatric disorders.CURRENT TOPICS IN MEDICINAL CHEMISTRY, Volume 8, Number 12. 93
Nitric Oxide: Implications For The Etiology & Treatment Of Central Nervous System Disorders 91
Neurodegenerative Disorders: From Molecules to Man. Part II 82
Totale 9.990
Categoria #
all - tutte 32.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 0 0 0 0 0 97 91
2021/2022629 24 167 3 9 39 13 24 24 89 56 26 155
2022/2023799 97 151 24 75 102 134 47 52 82 1 24 10
2023/2024336 11 73 21 40 21 87 25 23 0 1 5 29
2024/2025876 25 27 32 98 22 30 55 63 51 86 149 238
2025/20263.364 185 119 190 178 289 398 459 318 259 891 78 0
Totale 9.990